首页> 外文期刊>BMC Pregnancy and Childbirth >Perinatal outcomes of neonates born from different endometrial preparation protocols after frozen embryo transfer: a retrospective cohort study
【24h】

Perinatal outcomes of neonates born from different endometrial preparation protocols after frozen embryo transfer: a retrospective cohort study

机译:冷冻胚胎转移后不同子宫内膜制剂方案出生的新生儿的围产期结果:回顾性队列研究

获取原文

摘要

Previous studies have focused on pregnancy outcomes after frozen embryo transfer (FET) performed using different endometrial preparation protocols. Few studies have evaluated the effect of endometrial preparation on pregnancy-related complications. This study was designed to explore the association between different endometrial preparation protocols and adverse obstetric and perinatal complications after FET. We retrospectively included all FET cycles (n?=?12,950) in our hospital between 2010 and 2017, and categorized them into three groups, natural cycles (NC), hormone replacement therapy (HRT) and ovarian stimulation (OS) protocols. Pregnancy-related complications and subsequent neonatal outcomes were compared among groups. Among all 12,950 FET cycles, the live birth rate was slightly lower for HRT cycles than for NC (HRT vs. NC: 28.15% vs. 31.16%, p??0.001). The pregnancy loss rate was significantly higher in OS or HRT cycles than in NC (HRT vs. NC: 17.14% vs. 10.89%, p??0.001; OS vs. NC: 16.44% vs. 10.89%, p?=?0.001). Among 3864 women with live birth, preparing the endometrium using OS or HRT protocols increased the risk of preeclampsia, and intrahepatic cholestasis of pregnancy (ICP) in both singleton and multiple deliveries. Additionally, OS and HRT protocols increased the risk of low birth weight (LBW) and small for gestational age (SGA) in both singletons and multiples after FET. Compared with HRT or OS protocols, preparing the endometrium with NC was associated with the decreased risk of pregnancy-related complications, as well as the decreased risk of LBW and SGA after FET.
机译:以前的研究专注于使用不同子宫内膜制剂方案进行的冷冻胚胎转移(FET)后的妊娠结果。很少有研究评估子宫内膜制剂对妊娠相关并发症的影响。本研究旨在探讨FET后不同子宫内膜制剂方案和不良产科和围产期并发症之间的关联。我们回顾性地包括在2010年至2017年期间的所有FET周期(N?= 12,950),并将它们分为三组,天然循环(NC),激素替代疗法(HRT)和卵巢刺激(OS)协议。在群体中比较了与妊娠相关的并发症和随后的新生儿结果。在所有12,950个FET周期中,HRT循环的活率略低于NC(HRT与NC:28.15%vs.31.16%,P≤≤0.001)。 OS或HRT循环中的妊娠损失率明显高于NC(HRT与NC:17.14%Vs.10.89%,p≤0.0.0.010.0℃:16.44%与10.89%,p?= ?0.001)。在3864名患有活生生的女性中,使用OS或HRT方案制备子宫内膜,增加了Preclampsia的风险,并且在单身和多个交付中增加了妊娠(ICP)的肝内胆碱。此外,OS和HRT协议增加了在FET中的单身和妊娠年龄(SGA)的低出生体重(LBW)和小的风险,并且在FET之后倍增。与HRT或OS协议相比,制备NC的子宫内膜与妊娠相关并发症的风险降低有关,以及FET后LBW和SGA的风险降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号